ONCOMED PHARMACEUTICALS INC's ticker is OMED and the CUSIP is 68234X102.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2017 | $160,000 | -5.3% | 17,400 | +18.0% | 0.00% | 0.0% |
| Q3 2016 | $169,000 | -2.9% | 14,742 | +4.1% | 0.00% | 0.0% |
| Q2 2016 | $174,000 | +15.2% | 14,161 | -5.3% | 0.00% | 0.0% |
| Q1 2016 | $151,000 | -54.9% | 14,959 | +0.6% | 0.00% | -66.7% |
| Q4 2015 | $335,000 | +86.1% | 14,869 | +37.2% | 0.00% | +200.0% |
| Q3 2015 | $180,000 | -26.2% | 10,834 | 0.0% | 0.00% | -50.0% |
| Q2 2015 | $244,000 | -8.3% | 10,834 | +5.1% | 0.00% | 0.0% |
| Q1 2015 | $266,000 | +18.8% | 10,310 | 0.0% | 0.00% | 0.0% |
| Q4 2014 | $224,000 | +14.9% | 10,310 | 0.0% | 0.00% | +100.0% |
| Q3 2014 | $195,000 | -18.4% | 10,310 | +0.4% | 0.00% | -50.0% |
| Q2 2014 | $239,000 | – | 10,270 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| BVF INC/IL | 4,108,815 | $4,273,000 | 0.48% |
| Birchview Capital, LP | 372,557 | $387,000 | 0.24% |
| Perceptive Advisors | 1,719,111 | $1,787,000 | 0.05% |
| Fondren Management LP | 25,136 | $26,000 | 0.02% |
| Cannell & Co. | 281,983 | $293,000 | 0.01% |
| APPLETON PARTNERS INC/MA | 66,206 | $69,000 | 0.01% |
| Quinn Opportunity Partners LLC | 66,162 | $69,000 | 0.01% |
| NJ State Employees Deferred Compensation Plan | 38,000 | $40,000 | 0.01% |
| Candriam S.C.A. | 380,000 | $395,000 | 0.01% |
| PRIMECAP MANAGEMENT CO/CA/ | 5,451,400 | $5,669,000 | 0.00% |